MARKER THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent, Diluted
MARKER THERAPEUTICS, INC. (MRKR) reported Net Income (Loss) Attributable to Parent, Diluted of -$10.98 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-23.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2018-03-23
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2017-12-31 was -$2.68M.
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2017-09-30 was -$3.99M.
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2017-06-30 was -$1.89M, a 183.15% decline year-over-year.
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2017-03-31 was -$2.42M.
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for fiscal 2017 was -$10.98M.
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for fiscal 2016 was -$5.31M.
- MARKER THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for fiscal 2015 was -$34.07M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 3 month | Net Income (Loss) Attributable to Parent, Diluted 3 month as first filed | Net Income (Loss) Attributable to Parent, Diluted 6 month | Net Income (Loss) Attributable to Parent, Diluted 6 month as first filed | Net Income (Loss) Attributable to Parent, Diluted 9 month | Net Income (Loss) Attributable to Parent, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | -$2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$6.67M derived: sum of 2 quarters · filed 2018-03-23 | -$8.56M derived: sum of 3 quarters · filed 2018-03-23 | -$10.98M 10-K · filed 2018-03-23 | ||
| 2017-09-30 | -$3.99M 10-Q · filed 2017-11-14 | -$5.88M derived: sum of 2 quarters · filed 2017-11-14 | -$8.30M 10-Q · filed 2017-11-14 | -$9.88M derived: sum of 4 quarters · filed 2018-03-23 | ||
| 2017-06-30 | -$1.89M 10-Q · filed 2017-08-07 | -$4.31M 10-Q · filed 2017-08-07 | -$5.89M derived: sum of 3 quarters · filed 2018-03-23 | -$7.99M derived: sum of 4 quarters · filed 2018-03-23 | ||
| 2017-03-31 | -$2.42M derived: 10-K 12 month − 3 quarters · filed 2018-03-23 | -$4.00M derived: sum of 2 quarters · filed 2018-03-23 | -$6.10M derived: sum of 3 quarters · filed 2018-03-23 | -$3.82M derived: sum of 4 quarters · filed 2018-03-23 | ||
| 2016-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$3.68M derived: sum of 2 quarters · filed 2018-03-23 | -$1.40M derived: sum of 3 quarters · filed 2018-03-23 | -$5.31M 10-K · filed 2018-03-23 | ||
| 2016-09-30 | -$2.10M 10-Q · filed 2017-11-14 | $174.18K derived: sum of 2 quarters · filed 2017-11-14 | -$3.73M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $2.28M 10-Q · filed 2017-08-07 | $2.28M 10-Q · filed 2016-08-15 | -$1.27M 10-Q · filed 2017-08-07 | -$1.27M 10-Q · filed 2016-08-15 | ||
| 2015-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $26.85M derived: sum of 2 quarters · filed 2017-03-14 | -$33.37M derived: sum of 3 quarters · filed 2017-03-14 | -$34.07M 10-K · filed 2017-03-14 | ||
| 2015-09-30 | $28.50M 10-Q · filed 2016-11-04 | -$31.71M derived: sum of 2 quarters · filed 2016-11-04 | -$32.41M 10-Q · filed 2016-11-04 | |||
| 2015-06-30 | -$60.22M 10-Q · filed 2016-08-15 | -$60.92M 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |